Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 430569, 14 pages
http://dx.doi.org/10.1155/2015/430569
Research Article

Mechanical Stress Promotes Cisplatin-Induced Hepatocellular Carcinoma Cell Death

1Biotechnology Program, School of Sciences and Engineering, The American University in Cairo, AUC Avenue, New Cairo 11835, Egypt
2Department of Biology, School of Sciences and Engineering, The American University in Cairo, AUC Avenue, New Cairo 11835, Egypt
3Department of Mechanical and Industrial Engineering, Ryerson University, 350 Victoria Street, Toronto, ON, Canada M5B 2K3
4Martin Orthopaedic Biomechanics Lab, St. Michael’s Hospital, 209 Victoria Street, Toronto, ON, Canada M5B 1W8
5Department of Mechanical and Industrial Engineering, University of Toronto, Toronto, ON, Canada M5S 3G8

Received 13 June 2014; Revised 18 September 2014; Accepted 13 October 2014

Academic Editor: Vickram Ramkumar

Copyright © 2015 Laila Ziko et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Hanahan and R. A. Weinberg, “Hallmarks of cancer: the next generation,” Cell, vol. 144, no. 5, pp. 646–674, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Galluzzi, L. Senovilla, I. Vitale et al., “Molecular mechanisms of cisplatin resistance,” Oncogene, vol. 31, no. 15, pp. 1869–1883, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Fung and D. J. Vaughn, “Complications associated with chemotherapy in testicular cancer management,” Nature Reviews Urology, vol. 8, no. 4, pp. 213–222, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Pabla and Z. Dong, “Curtailing side effects in chemotherapy: a tale of PKCδ in cisplatin treatment,” Oncotarget, vol. 3, no. 1, pp. 107–111, 2012. View at Google Scholar · View at Scopus
  5. R. Paus, I. S. Haslam, A. A. Sharov, and V. A. Botchkarev, “Pathobiology of chemotherapy-induced hair loss,” The Lancet Oncology, vol. 14, no. 2, pp. e50–e59, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. L. P. Rybak, C. A. Whitworth, D. Mukherjea, and V. Ramkumar, “Mechanisms of cisplatin-induced ototoxicity and prevention,” Hearing Research, vol. 226, no. 1-2, pp. 157–167, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Cervello, J. A. McCubrey, A. Cusimano, N. Lampiasi, A. Azzolina, and G. Montalto, “Targeted therapy for hepatocellular carcinoma: novel agents on the horizon,” Oncotarget, vol. 3, no. 3, pp. 236–260, 2012. View at Google Scholar · View at Scopus
  8. A. Wicki and C. Rochlitz, “Targeted therapies in breast cancer,” Swiss Medical Weekly, vol. 142, Article ID w13550, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Pless and U. Weinberg, “Tumor treating fields: concept, evidence and future,” Expert Opinion on Investigational Drugs, vol. 20, no. 8, pp. 1099–1106, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. V. Klika and F. Maršík, “Coupling effect between mechanical loading and chemical reactions,” Journal of Physical Chemistry B, vol. 113, no. 44, pp. 14689–14697, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. C.-Y. Li, J.-S. Lee, Y.-G. Ko, J.-I. Kim, and J.-S. Seo, “Heat shock protein 70 inhibits apoptosis downstream of cytochrome c release and upstream of caspase-3 activation,” The Journal of Biological Chemistry, vol. 275, no. 33, pp. 25665–25671, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. J. T. Silver and E. G. Noble, “Regulation of survival gene hsp70,” Cell Stress and Chaperones, vol. 17, no. 1, pp. 1–9, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Bates and K. H. Vousden, “Mechanisms of p53-mediated apoptosis,” Cellular and Molecular Life Sciences, vol. 55, no. 1, pp. 28–37, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. E. C. LaCasse, S. Baird, R. G. Korneluk, and A. E. MacKenzie, “The inhibitors of apoptosis (IAPs) and their emerging role in cancer,” Oncogene, vol. 17, no. 25, pp. 3247–3259, 1998. View at Google Scholar · View at Scopus
  15. S. K. Yeap, N. B. Alitheen, A. M. Ali et al., “Effect of Rhaphidophora korthalsii methanol extract on human peripheral blood mononuclear cell (PBMC) proliferation and cytolytic activity toward HepG2,” Journal of Ethnopharmacology, vol. 114, no. 3, pp. 406–411, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Kasherman, S. Sturup, and D. Gibson, “Is glutathione the major cellular target of cisplatin? A study of the interactions of cisplatin with cancer cell extracts,” Journal of Medicinal Chemistry, vol. 52, no. 14, pp. 4319–4328, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Zayed, T. Shoeib, S. E. Taylor et al., “Determination of Pt-DNA adducts and the sub-cellular distribution of Pt in human cancer cell lines and the leukocytes of cancer patients, following mono- or combination treatments, by inductively-coupled plasma mass spectrometry,” International Journal of Mass Spectrometry, vol. 307, no. 1–3, pp. 70–78, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. E. M. Moustafa, C. L. Camp, A. S. Youssef et al., “Oxaliplatin complexes with carnosine and its derivatives: in vitro cytotoxicity, mass spectrometric and computational studies with a focus on complex fragmentation,” Metallomics, vol. 5, no. 11, pp. 1537–1546, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Alpsoy, G. Akcayoglu, and H. Sahin, “Anti-oxidative and anti-genotoxic effects of carnosine on human lymphocyte culture,” Human and Experimental Toxicology, vol. 30, no. 12, pp. 1979–1985, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. B. B. Knowles, C. C. Howe, and D. P. Aden, “Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen,” Science, vol. 209, no. 4455, pp. 497–499, 1980. View at Publisher · View at Google Scholar · View at Scopus
  21. L. F. Qin and I. O. L. Ng, “Induction of apoptosis by cisplatin and its effect on cell cycle-related proteins and cell cycle changes in hepatoma cells,” Cancer Letters, vol. 175, no. 1, pp. 27–38, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. H.-R. Kim, H.-J. Park, J. H. Park, S. J. Kim, K. Kim, and J. Kim, “Characteristics of the killing mechanism of human natural killer cells against hepatocellular carcinoma cell lines HepG2 and Hep3B,” Cancer Immunology, Immunotherapy, vol. 53, no. 5, pp. 461–470, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. L. W. Kraiss, A. S. Weyrich, N. M. Alto et al., “Fluid flow activates a regulator of translation, p70/p85 S6 kinase, in human endothelial cells,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 278, no. 5, pp. H1537–H1544, 2000. View at Google Scholar · View at Scopus
  24. A. Dardik, L. Chen, J. Frattini et al., “Differential effects of orbital and laminar shear stress on endothelial cells,” Journal of Vascular Surgery, vol. 41, no. 5, pp. 869–880, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. W. Pingqing, L. Zhizhong, O. Keqing et al., “Tanshinone II-A induced apoptosis of HepG2: involvement of p53, Bcl-2 and Bax,” in Proceedings of the 3rd International Conference on Bioinformatics and Biomedical Engineering (iCBBE '09), pp. 1–4, June 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Ye, J. Qi, G. Li, D. Tao, and S. Song, “The effect of HBx gene on the apoptosis of hepatic cells,” Journal of Huazhong University of Science and Technology—Medical Science, vol. 27, no. 2, pp. 167–169, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Chuma, M. Sakamoto, K. Yamazaki et al., “Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma,” Hepatology, vol. 37, no. 1, pp. 198–207, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Lacelle, S. Xu, and E. Wang, “Identification of high caspase-3 mRNA expression as a unique signature profile for extremely old individuals,” Mechanisms of Ageing and Development, vol. 123, no. 8, pp. 1133–1144, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. H.-R. Kim, K. Kim, K.-H. Lee, S. J. Kim, and J. Kim, “Inhibition of casein kinase 2 enhances the death ligand- and natural kiler cell-induced hepatocellular carcinoma cell death,” Clinical & Experimental Immunology, vol. 152, no. 2, pp. 336–344, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Porras, S. Zuluaga, E. Black et al., “P38α mitogen-activated protein kinase sensitizes cells to apoptosis induced by different stimuli,” Molecular Biology of the Cell, vol. 15, no. 2, pp. 922–933, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Huiskes, R. Rulmerman, G. H. van Lenthe, and J. D. Janssen, “Effects of mechanical forces on maintenance and adaptation of form in trabecular bone,” Nature, vol. 405, no. 6787, pp. 704–706, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. V. Klika, “Comparison of the effects of possible mechanical stimuli on the rate of biochemical reactions,” The Journal of Physical Chemistry B, vol. 114, no. 32, pp. 10567–10572, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. P. T. Avval, V. Klika, and H. Bougherara, “Predicting bone remodeling in response to total hip arthroplasty: computational study using mechanobiochemical model,” Journal of Biomechanical Engineering, vol. 136, no. 5, Article ID 051002, 12 pages, 2014. View at Publisher · View at Google Scholar
  34. P. Hendricks, F. J. Diaz, S. Schmitt, G. S. Sittampalam, and V. S. Nirmalanandhan, “Effects of respiratory mechanical forces on the pharmacological response of lung cancer cells to chemotherapeutic agents,” Fundamental & Clinical Pharmacology, vol. 26, no. 5, pp. 632–643, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. G. Cheng, J. Tse, R. K. Jain, and L. L. Munn, “Micro-environmental mechanical stress controls tumor spheroid size and morphology by suppressing proliferation and inducing apoptosis in cancer cells,” PLoS ONE, vol. 4, no. 2, Article ID e4632, 2009. View at Publisher · View at Google Scholar
  36. G. Waris and H. Ahsan, “Reactive oxygen species: role in the development of cancer and various chronic conditions,” Journal of Carcinogenesis, vol. 5, article 14, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. V. Cepeda, M. A. Fuertes, J. Castilla, C. Alonso, C. Quevedo, and J. M. Pérez, “Biochemical mechanisms of cisplatin cytotoxicity,” Anti-Cancer Agents in Medicinal Chemistry, vol. 7, no. 1, pp. 3–18, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Menon and K. A. Beningo, “Cancer cell invasion is enhanced by applied mechanical stimulation,” PLoS ONE, vol. 6, no. 2, Article ID e17277, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. J. M. Tse, G. Cheng, J. A. Tyrrell et al., “Mechanical compression drives cancer cells toward invasive phenotype,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 3, pp. 911–916, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. R. G. Pearson, “Hard and soft acids and bases, HSAB, part I: fundamental principles,” Journal of Chemical Education, vol. 45, no. 9, pp. 581–587, 1968. View at Publisher · View at Google Scholar · View at Scopus
  41. V. Brabec and J. Kasparkova, “Modifications of DNA by platinum complexes: relation to resistance of tumors to platinum antitumor drugs,” Drug Resistance Updates, vol. 8, no. 3, pp. 131–146, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. T. Torigoe, H. Izumi, H. Ishiguchi et al., “Cisplatin resistance and transcription factors,” Current Medicinal Chemistry-Anti-Cancer Agents, vol. 5, no. 1, pp. 15–27, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. A.-M. Florea and D. Büsselberg, “Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects,” Cancers, vol. 3, no. 1, pp. 1351–1371, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. M. S. Ricci and W.-X. Zong, “Chemotherapeutic approaches for targeting cell death pathways,” Oncologist, vol. 11, no. 4, pp. 342–357, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. C. Neidlinger-Wilke, H. J. Wilke, and L. Claes, “Cyclic stretching of human osteoblasts affects proliferation and metabolism: a new experimental method and its application,” Journal of Orthopaedic Research, vol. 12, no. 1, pp. 70–78, 1994. View at Publisher · View at Google Scholar · View at Scopus
  46. R. K. Jain, J. D. Martin, and T. Stylianopoulos, “The role of mechanical forces in tumor growth and therapy,” Annual Review of Biomedical Engineering, vol. 16, pp. 321–346, 2014. View at Google Scholar
  47. E. J. Baran, “Metal Complexes of Carnosine,” Biochemistry (Moscow), vol. 65, no. 7, pp. 789–797, 2000. View at Google Scholar · View at Scopus
  48. M. E. Palm-Espling, C. D. Andersson, E. Björn, A. Linusson, and P. Wittung-Stafshede, “Determinants for simultaneous binding of copper and platinum to human chaperone Atox1: hitchhiking not hijacking,” PLoS ONE, vol. 8, no. 7, Article ID e70473, 2013. View at Publisher · View at Google Scholar · View at Scopus